Real-time enrollment status for this type 2 diabetes clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:27 AM UTC
| NCT Number | NCT06297603 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Type 2 Diabetes |
| Phase | Clinical Trial |
| Target Enrollment | 320 participants |
| Active Locations | 29 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | December 24, 2025 (Dec 24, 2025) |
As of March 2, 2026: Clinical trial NCT06297603 is currently active_not_recruiting participants. This clinical trial study for type 2 diabetes is not currently accepting new participants at 29 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06297603 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 29 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06297603 was last updated Dec 24, 2025 (December 24, 2025). HelloStudys verifies this status automatically.